» Authors » F Guaraldi

F Guaraldi

Explore the profile of F Guaraldi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 191
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Monami M, Gori D, Guaraldi F, Montalti M, Nreu B, Burioni R, et al.
Ann Ig . 2021 Nov; 34(4):344-357. PMID: 34821928
Background: The COVID-19 vaccination campaign began in Italy at the end of December 2020, with the primary aim of immunizing healthcare professionals, using the EMA approved mRNA vaccines (Comirnaty® by...
2.
Di Valerio Z, Montalti M, Guaraldi F, Tedesco D, Nreu B, Mannucci E, et al.
Ann Ig . 2021 Jul; 34(3):217-226. PMID: 34328496
Background. Vaccination is one of the most effective tools available to Public Health. Its potential usefulness is threatened by the rise of vaccine hesitancy among the general population, which has...
3.
Beccuti G, Guaraldi F, Natta G, Cambria V, Prencipe N, Cicolin A, et al.
J Endocrinol Invest . 2020 Dec; 44(8):1699-1706. PMID: 33314003
Introduction: Impulse control disorders (ICDs) have been described as a side effect of dopamine agonists (DAs) in neurological as well as endocrine conditions. Few studies have evaluated the neuropsychological effect...
4.
Guaraldi F, Zoli M, Asioli S, Corona G, Gori D, Friso F, et al.
J Endocrinol Invest . 2020 Mar; 43(10):1463-1471. PMID: 32215861
Purpose: To assess outcomes and predictors of early and long-term remission in patients with Cushing's disease (CD) due to ACTH-secreting adenomas treated via endoscopic endonasal approach (EEA). Methods: This is...
5.
Fatti L, Cangiano B, Vitale G, Persani L, Mantovani G, Sala E, et al.
Pituitary . 2019 Apr; 22(5):552-560. PMID: 31032537
Purpose: Arthropathy is a common and disabling complication of acromegaly. Since in this condition radiological findings rarely correspond to functional impairment, we elected to quantify in a large cohort of...
6.
Corona G, Rastrelli G, Guaraldi F, Tortorici G, Reismann Y, Sforza A, et al.
Expert Opin Drug Saf . 2019 Apr; 18(4):321-332. PMID: 30998433
Introduction: The cardiovascular (CV) safety of testosterone replacement therapy (TRT) remains a crucial issue in the management of subjects with late-onset hypogonadism. The authors systematically reviewed and discussed the available...
7.
Guaraldi F, Gori D, Calderoni P, Castiello E, Pratelli L, Leporati M, et al.
J Endocrinol Invest . 2019 Mar; 42(9):1117-1124. PMID: 30877658
Background: Hypothalamic-pituitary-adrenal axis (HPAA) suppression is the most common and dangerous, although often unrecognized and untreated, side effect of glucocorticoid administration. The risk and duration depend both on patient and...
8.
Asioli S, Righi A, Iommi M, Baldovini C, Ambrosi F, Guaraldi F, et al.
Eur J Endocrinol . 2018 Nov; 180(2):127-134. PMID: 30481158
Objective and design A clinicopathological score has been proposed by Trouillas et al. to predict the evolution of pituitary adenomas. Aim of our study was to perform an independent external...
9.
Gori D, Guaraldi F, Cinocca S, Moser G, Rucci P, Fantini M
Obes Sci Pract . 2017 Oct; 3(3):235-248. PMID: 29071100
Objective: This review and meta-analysis aim at updating a previous meta-analysis carried out by Waters . on the efficacy of interventions aimed at preventing childhood obesity and at identifying predictors...
10.
Guaraldi F, La Selva R, Sama M, DAngelo V, Gori D, Fava P, et al.
J Endocrinol Invest . 2017 Oct; 41(5):549-556. PMID: 29043574
Purpose: Autoimmune diseases are typically associated with immune checkpoints blockade. This study aims at assessing, in real-life clinical practice, the prevalence and impact of thyroid disorders induced by immune checkpoint...